ULCERATIVE COLITIS DRUG MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Ulcerative Colitis Drug Market, By Molecule Type (Biologics and Small Molecules), By Drug Class (Aminosalicylates (Mesalamine (Asacol HD, Lialda), Olsalazin), Corticosteroids (Budesonide (Uceris), Prednisone), Anti-TNF Biologics (Infliximab (Remicade) Adalimumab (Humira)), Integrin Receptor Antagonists, (Vedolizumab (Entyvio)), Janus Kinase (JAK) Inhibitors, (Tofacitinib (Xeljanz), Upadacitinib (Rinvoq)), Interleukin (IL)-12/23 Inhibitors, (Ustekinumab (Stelara), Risankizumab (Skyrizi)), Sphingosine 1-Phosphate (S1P) Receptor Modulators, (Ozanimod (Zeposia), Etrasimod (Velsipity)), Immunosuppressants, (Azathioprine, 6-Mercaptopurine), Others), By Disease Type (Ulcerative Proctitis, Left-Sided Colitis, Pancolitis, and Fulminant Colitis), By Disease Severity (Mild Ulcerative Colitis, Moderate Ulcerative Colitis, and Severe Ulcerative Colitis), By Route of Administration (Oral, Parenteral, and Rectal), By Age Group (Adults, Pediatrics, and Geriatric), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals and Clinics, Infusion Centers, Specialty Gastroenterology Clinics, Ambulatory Surgical Centers (ASCs), Research and Diagnostic Laboratories, and Home Healthcare Settings), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 17 Mar, 2026
Code: CMI8592
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Ulcerative Colitis Drug Market, By Molecule Type
  - Global Ulcerative Colitis Drug Market, By Drug Class
  - Global Ulcerative Colitis Drug Market, By Disease Type
  - Global Ulcerative Colitis Drug Market, By Disease Severity
  - Global Ulcerative Colitis Drug Market, By Route of Administration
  - Global Ulcerative Colitis Drug Market, By Age Group
  - Global Ulcerative Colitis Drug Market, By Gender
  - Global Ulcerative Colitis Drug Market, By Distribution Channel
  - Global Ulcerative Colitis Drug Market, By End User
  - Global Ulcerative Colitis Drug Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Ulcerative Colitis Drug Market, By Molecule Type, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Biologics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Small Molecules
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Aminosalicylates
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Mesalamine (Asacol HD, Lialda)
    - Olsalazin
- Corticosteroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Budesonide (Uceris)
    - Prednisone
- Anti-TNF Biologics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Infliximab (Remicade)
    - Adalimumab (Humira)
- Integrin Receptor Antagonists
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Vedolizumab (Entyvio)
- Janus Kinase (JAK) Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Tofacitinib (Xeljanz)
    - Upadacitinib (Rinvoq)
- Interleukin (IL)-12/23 Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Ustekinumab (Stelara)
    - Risankizumab (Skyrizi)
- Sphingosine 1-Phosphate (S1P) Receptor Modulators
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Ozanimod (Zeposia)
    - Etrasimod (Velsipity)
- Immunosuppressants
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Azathioprine
    - 6-Mercaptopurine
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Disease Type, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Ulcerative Proctitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Left-Sided Colitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pancolitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fulminant Colitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Disease Severity, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Mild Ulcerative Colitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Moderate Ulcerative Colitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Severe Ulcerative Colitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rectal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Adults
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatrics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Male
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Distribution Channel, 2026 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals and Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infusion Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Gastroenterology Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Diagnostic Laboratories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Healthcare Settings
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Ulcerative Colitis Drug Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive landscape
- AbbVie Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson (Janssen Biotech)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Amgen Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gilead Sciences Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Biogen Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Celltrion Healthcare Co Ltd
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Eisai Co Ltd
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on 'Ulcerative Colitis Drug Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now